Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Neuroprotection: Reduction in the risk of occurrence of Grade 3-4 cumulative peripheral sensory neuropathy (PSN) relative to cumulative dose of oxaliplatin.
Critère d'inclusion
- Patients with metastatic colorectal cancer treated with oxaliplatin/5-FU/LV at risk of cumulative peripheral sensory neuropathy PSN relative to cumulative dose of oxaliplatin